{"name": "AstraZeneca",
 "permalink": "astrazeneca",
 "crunchbase_url": "http://www.crunchbase.com/company/astrazeneca",
 "homepage_url": "http://www.astrazeneca.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1992,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": null,
 "alias_list": "",
 "email_address": "",
 "phone_number": "44 20 7304 5000",
 "description": "pharmaceutical company",
 "created_at": "Wed Nov 12 13:30:06 UTC 2008",
 "updated_at": "Mon Jun 10 07:12:04 UTC 2013",
 "overview": "\u003Cp\u003EThey discover new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       37],
      "assets/images/resized/0006/4083/64083v1-max-150x150.png"],
     [[176,
       44],
      "assets/images/resized/0006/4083/64083v1-max-250x250.png"],
     [[176,
       44],
      "assets/images/resized/0006/4083/64083v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Pharmaceutical development and technical services",
    "person":
     {"first_name": "Cheryl",
      "last_name": "Larrivee-Elkins",
      "permalink": "cheryl-larrivee-elkins",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0025/1928/251928v1-max-150x150.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1928/251928v1-max-250x250.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1928/251928v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Executive Director, Chemistry",
    "person":
     {"first_name": "Ronald",
      "last_name": "C. Griffith",
      "permalink": "ronald-c-griffith",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5864/255864v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Associate Principal Scientist",
    "person":
     {"first_name": "David",
      "last_name": "Higton",
      "permalink": "david-higton",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/7451/257451v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/7451/257451v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/7451/257451v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "GI Business Unit Head",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}},
   {"is_past": true,
    "title": "Principal Scientist",
    "person":
     {"first_name": "David",
      "last_name": "Higton",
      "permalink": "david-higton",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/7451/257451v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/7451/257451v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/7451/257451v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Text Mining Consultant",
    "person":
     {"first_name": "Raf",
      "last_name": "Podowski",
      "permalink": "raf-podowski",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0027/0157/270157v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/0157/270157v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0027/0157/270157v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [{"title": "Housing",
    "is_past": false,
    "provider":
     {"name": "HITPROM Real Estate",
      "permalink": "hitprom-real-estate",
      "image":
       {"available_sizes":
         [[[150,
            51],
           "assets/images/resized/0002/8358/28358v2-max-150x150.jpg"],
          [[250,
            85],
           "assets/images/resized/0002/8358/28358v2-max-250x250.jpg"],
          [[450,
            153],
           "assets/images/resized/0002/8358/28358v2-max-450x450.jpg"]],
        "attribution": null}}}],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 505000000.0,
    "price_currency_code": "USD",
    "term_code": "cash",
    "source_url": "http://www.fiercebiotech.com/press-releases/novexel-be-acquired-astrazeneca",
    "source_description": "Novexel to be Acquired by AstraZeneca",
    "acquired_year": 2009,
    "acquired_month": 12,
    "acquired_day": 23,
    "company":
     {"name": "Novexel",
      "permalink": "novexel",
      "image":
       {"available_sizes":
         [[[150,
            71],
           "assets/images/resized/0007/1317/71317v1-max-150x150.png"],
          [[217,
            104],
           "assets/images/resized/0007/1317/71317v1-max-250x250.png"],
          [[217,
            104],
           "assets/images/resized/0007/1317/71317v1-max-450x450.png"]],
        "attribution": null}}},
   {"price_amount": 443000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.worldpharmanews.com/astrazeneca/2450-astrazeneca-to-acquire-omthera-pharmaceuticals-including-nda-ready-novel-dyslipidemia-treatment-to-complement-cardiovascular-portfolio",
    "source_description": "AstraZeneca to acquire Omthera Pharmaceuticals including NDA-ready novel dyslipidemia treatment to complement cardiovascular portfolio ",
    "acquired_year": 2013,
    "acquired_month": 5,
    "acquired_day": 29,
    "company":
     {"name": "Omthera Pharmaceuticals",
      "permalink": "omthera-pharmaceuticals",
      "image":
       {"available_sizes":
         [[[150,
            61],
           "assets/images/resized/0008/2359/82359v2-max-150x150.jpg"],
          [[250,
            102],
           "assets/images/resized/0008/2359/82359v2-max-250x250.jpg"],
          [[266,
            109],
           "assets/images/resized/0008/2359/82359v2-max-450x450.jpg"]],
        "attribution": null}}},
   {"price_amount": 1150000000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.reuters.com/article/2013/06/10/us-astrazeneca-pearl-idUSBRE95904U20130610?feedType=RSS\u0026feedName=businessNews",
    "source_description": "AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion",
    "acquired_year": 2013,
    "acquired_month": 6,
    "acquired_day": 10,
    "company":
     {"name": "Pearl Therapeutics",
      "permalink": "pearl-therapeutics",
      "image":
       {"available_sizes":
         [[[150,
            56],
           "assets/images/resized/0005/0877/50877v2-max-150x150.jpg"],
          [[180,
            68],
           "assets/images/resized/0005/0877/50877v2-max-250x250.jpg"],
          [[180,
            68],
           "assets/images/resized/0005/0877/50877v2-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "HQ",
    "address1": "15 Stanhope Gate",
    "address2": "",
    "zip_code": "W1K 1LN",
    "city": "London",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [{"description": "AstraZeneca hands over $28M to team with Regulus on cardio pact",
    "stoned_year": 2012,
    "stoned_month": 8,
    "stoned_day": 15,
    "source_url": "http://www.fiercebiotech.com/story/astrazeneca-hands-over-28m-team-regulus-cardio-pact/2012-08-15?utm_source=rss\u0026utm_medium=rss",
    "source_text": "",
    "source_description": "AstraZeneca hands over $28M to team with Regulus on cardio pact",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "AstraZeneca",
      "permalink": "astrazeneca"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        126],
       "assets/images/resized/0006/4084/64084v1-max-150x150.jpg"],
      [[250,
        210],
       "assets/images/resized/0006/4084/64084v1-max-250x250.jpg"],
      [[450,
        379],
       "assets/images/resized/0006/4084/64084v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}